anti-IL8 mAb

DRUG2 trials

Sponsors

Bristol Myers Squibb International Corporation, Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Conditions

Adenocarcinoma of the Colon or rectosigmoid (considered as non-rectal)Advanced solid tumors

Phase 1

A Phase 1/2 Study of BMS-986253 in Combination with Nivolumab or Nivolumab plus Ipilimumab in Advanced Cancers

CompletedCTIS2023-509061-20-00

Bristol Myers Squibb International CorporationAdvanced solid tumors

Start: 2018-11-22End: 2025-12-04Target: 113Updated: 2025-12-23

Phase 2

Neoadjuvant immune checkpoint inhibition and novel IO combinations in early-stage colon cancer - the NICHE trial

RecruitingCTIS2024-513314-35-00

Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis StichtingAdenocarcinoma of the Colon or rectosigmoid (considered as non-rectal)

Start: 2017-01-20Target: 353Updated: 2025-10-28